Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Techno Medica CoTSE:6678 +1.43%83 EV-to-FCF is 4.50 as of Jul. 16, 2026, which is 19% below its 10-year median of 5.58. GuruFocus rates TSE:6678 with a GF Score™ of 83/100 and a GF Value™ of 円2,421.97 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 413 Medical Devices & Instruments companies, Techno Medica Co ranks better than 93.7% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Techno Medica Co's Enterprise Value is 円4,770 Mil.
Techno Medica Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was 円1,059 Mil. Therefore, Techno Medica Co's EV-to-FCF for today is 4.50.
The historical rank and industry rank for Techno Medica Co's EV-to-FCF or its related term are showing as below:
TSE:6678'
s EV-to-FCF Range Over the Past 10 Years
Min: 0.66 Med: 5.58 Max: 17.68
Current: 4.57
During the past 13 years, the highest EV-to-FCF of Techno Medica Co was 17.68. The lowest was 0.66. And the median was 5.58.
TSE:6678's EV-to-FCF is ranked better than 93.7% of 413
companies
in the Medical Devices & Instruments industry
Industry Median: 23.72
vs TSE:6678: 4.57
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Techno Medica Co's PE Ratio (TTM) for today is calculated as:
Techno Medica Co's share price for today is 円2062.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Techno Medica Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was 円155.280.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Techno Medica Co EV-to-FCF Related Terms
Techno Medica Co EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Techno Medica Co's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Techno Medica Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Techno Medica Co EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Techno Medica Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Techno Medica Co's EV-to-FCF falls into.
Techno Medica Co's current Enterprise Value is 円4,770 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Techno Medica Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was 円1,059 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Techno Medica Co (TSE:6678) has a EV-to-FCF of 4.50 as of Jul. 16, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Techno Medica Co and its competitors. This is 19% below median its historical median of 5.58. Over the past decade, Techno Medica Co's EV-to-FCF has ranged from 0.66 to 17.68. According to the industry distribution chart, Techno Medica Co ranks #26 out of 413 companies in the Medical Devices & Instruments industry, placing it in the top 6.3%.
Is Techno Medica Co's EV-to-FCF too high?
Techno Medica Co's current EV-to-FCF of 4.50 is 19% below median its 10-year median of 5.58. Over the past 10 years, this metric has ranged from a low of 0.66 to a high of 17.68. The Medical Devices & Instruments industry median EV-to-FCF is 23.72. Techno Medica Co's value of 4.50 is 81% below this industry median. Based on the distribution chart, Techno Medica Co ranks #26 out of 413 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Techno Medica Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Techno Medica Co's EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Techno Medica Co ranks #26 out of 413 companies for EV-to-FCF. This places Techno Medica Co in the top 6% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 23.72. Techno Medica Co's value of 4.50 is 81% below this benchmark. Historically, Techno Medica Co's own EV-to-FCF has ranged from 0.66 to 17.68 over the past decade. While the company's 10-year median is 5.58 vs. the industry median of 23.72, Techno Medica Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.72, based on 413 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Techno Medica Co's current EV-to-FCF of 4.50 is 81% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Techno Medica Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Techno Medica Co's current EV-to-FCF is 4.50, which is 19% below median its own 10-year median of 5.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Techno Medica Co stock overvalued right now?
Based on GuruFocus' analysis, Techno Medica Co (TSE:6678) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,421.97, compared to a current price of 円2,062.00 — trading 14.9% below its estimated fair value. The current EV-to-FCF is 4.50, which is 19% below median its 10-year median of 5.58 and 81% below the Medical Devices & Instruments industry median of 23.72. Techno Medica Co's overall GF Score™ is 83/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Techno Medica Co (TSE:6678), the current EV-to-FCF is 4.50 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Techno Medica Co (TSE:6678) Overvalued in 2026?
Based on GuruFocus' analysis, Techno Medica Co stock appears to be undervalued.
The current stock price of 円2,062.00 is trading 14.9% below its estimated GF Value™ of 円2,421.97.
GuruFocus considers Techno Medica Co to be Modestly Undervalued.
Key valuation signals for TSE:6678:
EV-to-FCF: 4.50 (19% below median its 10-year median of 5.58)
GF Value™: 円2,421.97 vs. price of 円2,062.00 (14.9% below fair value)
Industry Position: 81% below the Medical Devices & Instruments median (#26 of 413)
No single metric tells the full story. See the TSE:6678 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Techno Medica Co Ltd is engaged in the research, development, manufacturing, and sales of medical and in vitro diagnostic products. The company's products classified under Test Tube preparation systems. Additionally, company also import and export medical equipment and Analytical instrument for clinical examination.
83GF Score
Get the complete analysis for TSE:6678
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6678 has been successfully added to your 
